Xylem Inc.
XYL · NYSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $28 | $25 | $20 | $22 |
| - Cash | $1 | $1 | $1 | $1 |
| + Debt | $2 | $2 | $2 | $3 |
| Enterprise Value | $29 | $26 | $21 | $23 |
| Revenue | $9 | $7 | $6 | $5 |
| % Growth | 16.3% | 33.4% | 6.3% | – |
| Gross Profit | $3 | $3 | $2 | $2 |
| % Margin | 37.5% | 36.9% | 37.7% | 38% |
| EBITDA | $2 | $1 | $1 | $1 |
| % Margin | 19.8% | 15.2% | 13.1% | 16% |
| Net Income | $1 | $1 | $0 | $0 |
| % Margin | 10.4% | 8.3% | 6.4% | 8.2% |
| EPS Diluted | 3.65 | 2.79 | 1.96 | 2.35 |
| % Growth | 30.8% | 42.3% | -16.6% | – |
| Operating Cash Flow | $1 | $1 | $1 | $1 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | $1 | $1 | $0 | $0 |